Treatment of Adolescents with Comorbid OCD and ADHD

Introduction to Treatment

The American Academy of Child and Adolescent Psychiatry recommends beginning with cognitive-behavioral therapy (CBT) for OCD while simultaneously initiating stimulant medication for ADHD, then adding an SSRI if OCD symptoms persist after ADHD treatment is optimized 1

If OCD symptoms are severe, the American Academy of Child and Adolescent Psychiatry suggests beginning with SSRI medication plus supportive therapy before initiating CBT 1
For adolescents with moderate-to-severe ADHD impairment, stimulant therapy should be initiated regardless of concurrent OCD treatment 2
The presence of OCD is not a contraindication to stimulant therapy, and both conditions can be treated concurrently 2

The American Academy of Child and Adolescent Psychiatry recommends starting with long-acting stimulant formulations as first-line treatment for ADHD 3
Initial doses should be low, with 5 mg methylphenidate or 2.5 mg amphetamine equivalent, titrating weekly in 5-10 mg increments for methylphenidate or 2.5-5 mg for amphetamines 3
Stimulants work rapidly, allowing quick assessment of ADHD response 2

CBT delivered by expert psychotherapists is the best first-line option for OCD, according to the American Academy of Child and Adolescent Psychiatry 1
If CBT expertise is unavailable, starting with medication may be the only evidence-based intervention practically available 1
If ADHD symptoms improve with stimulants but OCD symptoms persist, an SSRI should be added to the stimulant regimen 2
There are no significant drug-drug interactions between stimulants and SSRIs, making combination therapy safe 2

Maximum methylphenidate dose is 60 mg daily, though expert consensus often limits to 40 mg daily 3
Maximum amphetamines dose is 40 mg daily 3
Long-acting formulations provide superior adherence and consistent symptom control throughout the day 3
SSRIs remain weight-neutral with long-term use 2

Atomoxetine can be considered if stimulants are contraindicated, though it requires 2-4 weeks for full effect versus immediate stimulant response 2
Atomoxetine carries an FDA black box warning for suicidal ideation, requiring close monitoring especially when combined with SSRIs 2

Height, weight, blood pressure, and pulse should be monitored at baseline and regularly during treatment 2
Suicidality and clinical worsening should be monitored, particularly during the first few months of SSRI treatment or at dose changes 2
Sleep disturbances and appetite changes are common adverse effects 2
Both parent and teacher ratings using standardized scales should be obtained at each visit during titration 3

MAO inhibitors should not be used concurrently with stimulants or SSRIs due to risk of hypertensive crisis 2
Stimulants should not be assumed to worsen OCD symptoms, and emerging evidence suggests they may improve obsessive-compulsive symptoms when ADHD is adequately treated 2
Stimulants should not be underdosed, and should be titrated to optimal effect within safe limits 3
ADHD treatment should not be delayed while waiting for OCD to improve, and both conditions can and should be treated simultaneously 2
Inadequate treatment of either condition negatively affects long-term outcomes, including academic performance and overall functioning 1

Once response is achieved, monitoring should continue at monthly intervals during maintenance 1
The maintenance phase focuses on sustaining response, maintaining adherence, and monitoring for late-onset side effects 1
ADHD and OCD should both be recognized as chronic conditions requiring ongoing management, according to the American Academy of Child and Adolescent Psychiatry and other guidelines 1, 4